Clinical Trials Browser

Phase 2 × Chemotherapy × camrelizumab × Clear all

NCT05821452 2023-04-20

Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma

Phase 2 Not yet recruiting

Chemotherapy